Company

NovaBay Pharmaceuticals

Rocket Ship Rating

Rocket Ship Rating: 98 out of 100

Also known as NovaBay Pharmaceuticals, Inc

Legal name: NovaBay Pharmaceuticals, Inc

novabay.com (opens in a new tab)

Open relationship map

Claim, correct or request removal

Record updated 29 September 2026

Funding snapshot

Total raised: $211MSEC form D sum, as of 2026-09-29Source (opens in a new tab)
Latest round: Round, $134M2026-01-16

Funding rounds

Round, 2026: $134M2026-01-16, SEC form D sold, 4 investors
Round, 2024: $226K2024-06-14, SEC form D sold, 5 investors
Round, 2024: $665K2024-03-24, SEC form D sold, 5 investors
Round, 2023: $555K2023-12-21, SEC form D sold, 5 investors
Round, 2023: $3M2023-05-01, SEC form D sold, 5 investors
Round, 2022: $3.2M2022-09-23, SEC form D sold, 4 investors
Round, 2022: $2.1M2022-09-09, SEC form D sold, 9 investors
Round, 2021: $15M2021-11-02, SEC form D sold, 7 investors
Round, 2020: 2020-07-20
Round, 2020: $1K2020-05-13, SEC form D sold
Round, 2020: 2020-05-01
Round, 2019: $2.7M2019-08-13, SEC form D sold, 3 investors
Round, 2019: $4.2M2019-08-13, SEC form D sold, 4 investors
Round, 2019: $2.4M2019-06-26, SEC form D sold, 3 investors
Round, 2018: $6M2018-02-05, SEC form D sold, 1 investor
More rounds: 3 earlier rounds recorded